The Recombinant Rhodopirellula baltica UPF0365 protein RB6291 is a recombinant protein derived from the marine bacterium Rhodopirellula baltica. This protein is of particular interest due to its unique characteristics and potential applications in biotechnology and microbiological research. Rhodopirellula baltica is a member of the Planctomycetes phylum, known for its distinctive cell compartmentalization and lack of peptidoglycan in its cell walls .
Protein Structure and Expression: The recombinant protein RB6291 is expressed in Escherichia coli and is fused with an N-terminal His tag, facilitating its purification and identification . It consists of 345 amino acids, making it a full-length protein.
Purity and Storage: The protein is available in a lyophilized powder form with a purity of greater than 90% as determined by SDS-PAGE. It is recommended to store it at -20°C or -80°C and to avoid repeated freeze-thaw cycles .
Amino Acid Sequence: The amino acid sequence of RB6291 includes a variety of motifs and domains that could be involved in different cellular functions, although specific roles are not well-documented .
Protein Function: While the specific function of the UPF0365 protein RB6291 is not well-documented, proteins from Rhodopirellula baltica often have unique roles due to the bacterium's distinctive cellular structure and metabolic pathways . The protein is sometimes referred to as a hypothetical protein or a flotillin-like protein, suggesting potential involvement in membrane organization or signaling .
Biotechnological Potential: The recombinant expression of proteins like RB6291 in E. coli highlights the potential for biotechnological applications, such as studying protein function, developing novel enzymes, or understanding bacterial cell biology .
Recombinant Rhodopirellula baltica UPF0365 protein RB6291 (RB6291) is found in functional membrane microdomains (FMMs), potentially equivalent to eukaryotic membrane rafts. These FMMs are highly dynamic and increase in number with cellular aging. Flotillins are believed to play a significant role in maintaining membrane fluidity.
KEGG: rba:RB6291
STRING: 243090.RB6291
For optimal stability and activity preservation of RB6291 protein preparations, researchers should follow these evidence-based protocols:
Storage temperature: Store at -20°C for regular use, or at -80°C for extended storage periods
Buffer composition: The protein is stable in Tris-based buffer with 50% glycerol, which has been optimized specifically for this protein
Freeze-thaw cycles: Repeated freezing and thawing should be strictly avoided as it can lead to protein denaturation and activity loss
Working aliquots: When actively using the protein, store working aliquots at 4°C for a maximum of one week to minimize freeze-thaw damage
When designing experiments, researchers should consider validating protein stability under their specific experimental conditions through activity assays or structural integrity tests (e.g., circular dichroism) before proceeding with complex studies.
When incorporating RB6291 in ELISA-based detection systems, researchers should address several methodological considerations:
Antibody selection: Since RB6291 is available as a recombinant protein, consider whether the detection antibodies recognize native epitopes or tag-dependent epitopes. The tag type for commercial RB6291 is determined during the production process and may vary between preparations
Blocking optimization: Design controlled experiments comparing different blocking agents (BSA, milk proteins, commercial blockers) to determine optimal signal-to-noise ratios specific to RB6291
Temperature conditions: Given RB6291's storage requirements, conduct comparative ELISA runs at different incubation temperatures (4°C, room temperature, 37°C) to determine optimal antigen-antibody interaction conditions
Validation controls: Include both positive controls (purified RB6291 at known concentrations) and negative controls (related proteins from the UPF0365 family) to establish specificity parameters
These methodological considerations align with general experimental design principles in immunoassay development, where control of variables is essential for reliable results2.
For investigating protein-protein interactions involving RB6291, researchers should employ a multi-method approach tailored to membrane-associated proteins:
Pull-down assays and co-immunoprecipitation:
Optimize detergent conditions that maintain RB6291's native conformation (given its potential membrane association)
Consider crosslinking approaches to stabilize transient interactions
Use recombinant RB6291 as both bait (immobilized) and prey (in solution) to validate bidirectional interactions
Surface Plasmon Resonance (SPR):
Proximity-based methods:
For cellular studies, consider FRET/BRET approaches with RB6291 fused to appropriate fluorophores
For in vitro studies, hydrogen-deuterium exchange mass spectrometry can map interaction interfaces
Computational prediction:
When interpreting data, researchers should consider the experimental design principles of appropriate controls and variable isolation to establish causality in observed interactions2.
Structural characterization of RB6291 presents several challenges, particularly due to its potential membrane association. A methodologically rigorous approach includes:
Each approach should include appropriate experimental controls to distinguish methodological artifacts from true structural features, aligning with fundamental principles of experimental design2.
For comprehensive functional characterization of RB6291, researchers should implement a systematic experimental design that addresses both in vitro and cellular contexts:
Sequence-based functional prediction:
In vitro biochemical assays:
Design activity screens based on predicted functions (e.g., binding assays, enzymatic activity tests)
Develop quantitative assays with appropriate positive and negative controls
Test activity under varying conditions (pH, temperature, ionic strength) to establish optimal parameters
Cellular studies:
Generate knockout/knockdown models in relevant cell systems
Complement with rescue experiments using recombinant RB6291
Analyze resulting phenotypes through transcriptomics, proteomics, or metabolomics approaches
Interactome mapping:
Identify potential binding partners through affinity purification-mass spectrometry
Validate key interactions through orthogonal methods
Place RB6291 within functional networks based on interaction data
These approaches embody the experimental design principle of testing hypotheses through multiple independent methods, increasing confidence in functional assignments2.
Post-translational modifications (PTMs) of RB6291 require specialized methodological approaches to detect, characterize, and determine their functional significance:
Mass spectrometry-based PTM mapping:
Employ multiple proteolytic digestion strategies to ensure complete sequence coverage of RB6291
Use enrichment techniques specific to predicted modifications (phosphorylation, glycosylation, etc.)
Implement both data-dependent and targeted MS approaches for comprehensive PTM detection
Site-directed mutagenesis for functional validation:
Generate RB6291 variants with modified potential PTM sites (e.g., Ser/Thr to Ala for phosphorylation)
Compare wildtype and mutant proteins in functional assays to determine PTM significance
Consider phosphomimetic mutations (e.g., Ser/Thr to Asp/Glu) for mechanistic studies
PTM-specific detection methods:
Develop or source PTM-specific antibodies for immunological detection
Use protein staining methods specific for certain PTMs (e.g., Pro-Q Diamond for phosphorylation)
Employ chemical labeling strategies for specific PTM types
Temporal dynamics studies:
Investigate PTM patterns under different conditions or time points
Correlate PTM changes with functional alterations
Map regulatory pathways affecting RB6291 PTMs
These methodological approaches align with experimental design principles of controlling variables and establishing causality between PTMs and protein function2.
A methodologically sound experimental design for investigating RB6291 stability across buffer conditions should include:
Buffer matrix design:
Stability assessment methods:
Thermal shift assays to determine melting temperatures under each condition
Activity assays to correlate structural stability with functional integrity
Size-exclusion chromatography to monitor aggregation propensity
Dynamic light scattering for solution homogeneity analysis
Long-term stability monitoring:
Statistical analysis plan:
Design experiments with appropriate replication (minimum n=3)
Implement two-way ANOVA to assess interaction between buffer components and temperature
Use post-hoc tests to identify optimal stability conditions
This approach embodies experimental design principles of systematically testing variables while maintaining appropriate controls2.
When designing expression systems for recombinant RB6291 production, researchers should implement a methodologically rigorous approach:
Host system selection rationale:
Evaluate prokaryotic systems (E. coli) for basic expression
Consider eukaryotic systems (yeast, insect cells) if post-translational modifications are critical
Assess cell-free systems for rapid prototyping of expression constructs
Construct design strategy:
Optimize codon usage for selected expression host
Design multiple constructs with varying purification tags (N-terminal, C-terminal, cleavable)
Consider solubility-enhancing fusion partners if membrane association causes expression challenges
Expression condition optimization:
Implement factorial design to test induction parameters (temperature, inducer concentration, time)
Evaluate growth media formulations to maximize yield while maintaining proper folding
Develop scalable protocols from small-scale screening to preparative-scale production
Purification strategy development:
Design multi-step purification schemes with orthogonal separation principles
Validate final product purity through multiple analytical techniques (SDS-PAGE, Western blot, mass spectrometry)
Confirm activity/structure of purified protein compared to native RB6291
This methodological framework allows researchers to systematically identify optimal conditions for recombinant RB6291 production while maintaining experimental rigor2.
When faced with contradictory results in RB6291 functional studies, researchers should implement this methodological framework:
Systematic variable analysis:
Create a comprehensive table comparing experimental conditions across contradictory studies
Identify critical differences in protein preparation (expression system, tags, purification method)
Evaluate buffer compositions, including the standard Tris-based buffer with 50% glycerol used for RB6291
Assess experimental timelines and temperature conditions
Methodological validation:
Reproduce key experiments with standardized protein preparations
Implement orthogonal methods to test the same functional hypothesis
Evaluate sensitivity and specificity of assays used in contradictory studies
Statistical reanalysis:
Calculate effect sizes and confidence intervals for contradictory results
Perform power analysis to determine if sample sizes were sufficient
Consider meta-analytical approaches if multiple datasets are available
Reconciliation strategies:
Develop testable hypotheses that could explain apparent contradictions
Design critical experiments specifically addressing these hypotheses
Consider context-dependent functions as a potential explanation
This approach exemplifies sound experimental design principles by systematically investigating variables that might explain contradictory results, rather than simply rejecting one set of findings2.
For rigorous analysis of RB6291 binding affinity data, researchers should implement these statistical methodologies:
Model selection and fitting:
Compare one-site versus multi-site binding models using information criteria (AIC, BIC)
Evaluate cooperative versus non-cooperative binding models if appropriate
Use global fitting approaches when analyzing multiple datasets simultaneously
Parameter estimation:
Calculate binding constants (KD) with appropriate confidence intervals
Determine association and dissociation rate constants (kon, koff) from kinetic data
Derive thermodynamic parameters (ΔG, ΔH, ΔS) from temperature-dependent studies
Validation approaches:
Implement bootstrapping or jackknife resampling to assess parameter robustness
Perform residual analysis to evaluate goodness of fit
Conduct sensitivity analysis to identify influential data points
Comparative analysis:
Use appropriate statistical tests (paired t-tests, ANOVA) when comparing binding under different conditions
Apply multiple comparison corrections when testing numerous conditions
Incorporate hierarchical models when analyzing related binding partners
These statistical approaches align with experimental design principles by providing quantitative frameworks for hypothesis testing and parameter estimation in binding studies2.
A comprehensive quality control framework for recombinant RB6291 preparations should include:
Purity assessment metrics:
SDS-PAGE with densitometry analysis (target: >95% purity)
High-performance liquid chromatography (HPLC) profile analysis
Mass spectrometry confirmation of intact mass and sequence coverage
Structural integrity validation:
Circular dichroism spectroscopy to confirm secondary structure content
Thermal shift assay to establish consistent melting temperature
Dynamic light scattering to verify monodispersity and absence of aggregation
Functional verification:
Activity assays relevant to predicted function
Binding assays if interaction partners are known
Comparative analysis against reference standard
Storage stability parameters:
These quality control metrics should be documented in a standardized format with defined acceptance criteria, ensuring batch-to-batch consistency and experimental reproducibility.
When encountering solubility or aggregation issues with RB6291, researchers should implement this methodological troubleshooting framework:
Systematic buffer optimization:
Screen pH ranges (5.5-9.0) with 0.5 unit increments
Test multiple buffer systems (Tris, phosphate, HEPES, MES)
Evaluate ionic strength effects (50-500 mM NaCl)
Assess stabilizing additives (glycerol, sucrose, arginine)
Consider specialized additives for membrane proteins if relevant
Physical parameter adjustment:
Optimize protein concentration to identify aggregation thresholds
Test temperature effects on solubility (4°C, room temperature)
Evaluate freeze-thaw protocols and their impact on aggregation
Analytical characterization:
Implement dynamic light scattering to quantify aggregation state
Use size-exclusion chromatography to separate and quantify different oligomeric forms
Apply analytical ultracentrifugation for detailed solution behavior analysis
Sequence-based intervention:
Identify aggregation-prone regions using computational prediction
Design constructs excluding problematic regions
Consider point mutations to improve solubility without compromising function
These troubleshooting approaches reflect experimental design principles by systematically varying conditions to isolate critical factors affecting RB6291 solubility and aggregation 2.